BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3362255)

  • 21. Clinical trial of an oral contraceptive containing desogestrel and ethinyl estradiol.
    Weijers MJ
    Clin Ther; 1982; 4(5):359-66. PubMed ID: 6461412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Less estrogen in new oral contraceptive.
    Am J Nurs; 2003 Apr; 103(4):111-2. PubMed ID: 12677126
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol.
    Akerlund M
    Acta Obstet Gynecol Scand Suppl; 1997; 164():63-5. PubMed ID: 9225641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sex hormones: inexpensive pills to poor women].
    Astrup N
    Sygeplejersken; 1988 Mar; 88(11):20-1. PubMed ID: 3388228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral contraception in diabetic women. A cross-over study on serum and high density lipoprotein (HDL) lipids and diabetes control during progestogen and combined estrogen/progestogen contraception.
    Rådberg T; Gustafson A; Skryten A; Karlsson K
    Horm Metab Res; 1982 Feb; 14(2):61-5. PubMed ID: 7040192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Jaundice after ovulation inhibiting steroids].
    Fritsch H; Kaess H
    Med Klin; 1969 May; 64(19):894-7. PubMed ID: 5772231
    [No Abstract]   [Full Text] [Related]  

  • 27. [Oral contraceptives causing chorea in a young woman].
    Liedholm LJ; Barajas F
    Lakartidningen; 1988 Feb; 85(6):448. PubMed ID: 3352422
    [No Abstract]   [Full Text] [Related]  

  • 28. [Inferior caval thrombosis and pulmonary thromboembolism as complications due to the use of oral hormonal contraceptives].
    Koroleva IM; Dolgushina LM
    Vestn Rentgenol Radiol; 2004; (4):47-9. PubMed ID: 15626235
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
    Ferreira AC; Montes MB; Franceschini SA; Toloi MR
    Int J Fertil Womens Med; 2001; 46(5):265-70. PubMed ID: 11720199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)].
    Urdinola J
    Adv Contracept; 1994 Jul; 10 Suppl 1():41-9. PubMed ID: 7839871
    [No Abstract]   [Full Text] [Related]  

  • 31. Mircette: a novel oral contraceptive. Introduction.
    Speroff L
    Am J Obstet Gynecol; 1998 Jul; 179(1):S1. PubMed ID: 9704811
    [No Abstract]   [Full Text] [Related]  

  • 32. Do hormonal contraceptives stimulate growth of neurofibromas? A survey on 59 NF1 patients.
    Lammert M; Mautner VF; Kluwe L
    BMC Cancer; 2005 Feb; 5():16. PubMed ID: 15703081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress in contraception: new technology.
    Linn ES
    Int J Fertil Womens Med; 2003; 48(4):182-91. PubMed ID: 13677551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of post-marketing safety and surveillance data for oral contraceptives containing norgestimate and ethinyl estradiol.
    Lippman JS; Shangold GA
    Int J Fertil Womens Med; 1997; 42(4):230-9. PubMed ID: 9309456
    [No Abstract]   [Full Text] [Related]  

  • 35. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transient ischaemic attack associated with the new contraceptive Yasmin.
    Vayá A; Mira Y; Ferrando F; Aznar J; García-Fuster MJ
    Thromb Res; 2003; 112(1-2):121. PubMed ID: 15013284
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents.
    Molina RC; Sandoval JZ; Montero AV; Oyarzún PG; Molina TG; González EA
    J Pediatr Adolesc Gynecol; 2009 Feb; 22(1):25-31. PubMed ID: 19232299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of a new oral contraceptive containing drospirenone.
    Shulman LP
    J Reprod Med; 2002 Nov; 47(11 Suppl):981-4. PubMed ID: 12497672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of ethinyl estradiol on C1s inhibitor: a new etiopathogenetic mechanism of angioedema. Case report.
    Bettoni L
    Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):49. PubMed ID: 15859360
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical experience with a low-dose contraceptive agent. European studies.
    Haspels AA
    J Reprod Med; 1983 Jan; 28(1 Suppl):71-6. PubMed ID: 6403703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.